Oxandrolone chemical structure
Find information on thousands of medical conditions and prescription drugs.

Oxandrin

Oxandrolone (Oxandrin) is an anabolic steroid created by Searle Laboratories under the trademark Anavar, and introduced into the US in 1964. It is taken orally, and unlike other steroids delivered in this manner, most of which are Class II steroids, the majority of its effects are due to reaction with the androgen receptor. In sufficient dosage, Oxandrolone is highly likely to bind well with the receptor, and is therefore a Class I steroid, while having few other side-effects. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
Methoxsalen
OCL
Octabenzone
Octanoic acid
Octopamine
Octreotide
Ofloxacin
Ofloxacin
Olanzapine
Omeprazole
Oncovin
Ondansetron
Opium
Oratane
Oretic
Orinase
Orlistat
Ornidazole
Ornithine
Orotic acid
Orphenadrine
Ortho Evra
Oruvail
Ovcon
Ovral
Ovrette
Oxaliplatin
Oxamniquine
Oxandrin
Oxandrolone
Oxaprozin
Oxazepam
Oxcarbazepine
Oxetine
Oxibendazole
Oxiracetam
Oxprenolol
Oxybenzone
Oxybuprocaine
Oxycodone
Oxycodone
Oxymetazoline
Oxymetholone
Oxymorphone
Oxytetracycline
Oxytocin
P
Q
R
S
T
U
V
W
X
Y
Z

The drug was prescribed for a number of medical disorders causing involuntary weight loss, in order to promote muscle regrowth. It had also been shown to be partially successful in treating cases of osteoporosis. However, in part due to bad publicity from its illegal use by bodybuilders, Oxandrolone was discontinued by Searle Laboratories in 1989. It was picked up by Bio-Technology General Corporation who, following successful clinical trials in 1995, released it under the tradename Oxandrin. It was approved for orphan drug status by the FDA in treating alcoholic hepatitis, Turner's syndrome, and weight loss caused by HIV. In addition, the drug has shown positive results in treating anaemia and hereditary angioedema. Clinical studies however have shown links between prolonged use of the drug and problems of liver toxicity similar to those found with other 17α-alkylated steroids. Even in small dosages, many users reported gastro-intestinal problems such as bloating, nausea, and diarrhoea.

Before the Controlled Substances Act was passed to restrict the production, sale, and usage of anabolic steroids, Oxandrolone's characteristics lent itself well towards use by female athletes. Its specificity targeting the androgen receptor meant that, unlike many other steroids, it had not been reported to cause stunted growth in younger users, and at typical dosage rarely caused noticeable masculinising effects outside of stimulating muscle growth. In addition, Oxandrolone does not aromatise at any dosage, and is not easily metabolised into DHT or oestrogen. As such, a typical dose of 20-30 mg provided elevated androgen levels for up to eight hours. To increase effectiveness, bodybuilders typically "stacked" the drug with others such as Dianabol, further enhancing body mass gain.

Read more at Wikipedia.org


[List your site here Free!]



Androgen therapy for effects of aging in older men
As the number and proportion of older men increase in the United States and elsewhere, therapy to promote healthy aging becomes more advantageous. Aging ...
Involuntary weight loss: interview with Lisa Capaldini, M.D
On April 19, 2005 we spoke to Lisa Capaldini, M.D., an HIV specialist in San Francisco who alerted us to metabolic complications of HIV and antiretroviral ...
Nutrition for a patient with COPD can be complicated
Learn how to advise him about the role of good nutrition in managing his disease. If your patient has chronic obstructive pulmonary disease (COPD), his ...
Savient Pharmaceuticals Files Citizens' Petition with the FDA for Oxandrin®; Requests FDA to Not Approve Any ANDA Prior to Expiration of Geriatric
EAST BRUNSWICK, N.J. -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNTE) an emerging specialty pharmaceuticals company focused on developing, manufacturing ...
Medicaid Rx spending up 23%; states respond with new strategies
State Medicaid programs spent 23% more on prescription drugs in 2002 than they did in 2001 (figure 1), and prescription costs now represent 16% of total ...
patient.com, 1 year later, The
Richard "Sal" Salcido, MD, and Kenneth Barner, PhD, have previously reported1,2 on their use of telemedicine to evaluate and manage the progress toward ...
Body cell mass repletion and improved quality of life in HIV-infected individuals receiving oxandrolone
ABSTRACT. Background: The aim of this study was to measure changes in body cell mass (BCM) and quality of life in HIV-infected individuals undergoing oxandrolone therapy. Previous studies on oxandrol
Savient Pharmaceuticals, Inc. Expands Oxandrin Marketing and Sales Focus to Include the Treatment of Involuntary Weight Loss Associated with Cancer
Business Editors/Health/Medical Writers BIOWIRE2K EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--June 30, 2003 Savient Pharmaceuticals, Inc. ("Savient") ...

Home Contact Resources Exchange Links ebay